Obagi Medical Products, Inc.Long Beach, CA, United States (NASDAQ (GM): OMPI)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Obagi Medical Financial Statements

Obagi Medical Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Obagi Medical Income Statement

  2007 2006 2005
Revenue ($ mil.) 102.7 78.0 64.9
Gross Profit ($ mil.) 84.6 64.5 53.4
Operating Income ($ mil.) 27.7 17.8 21.1
Total Net Income ($ mil.) 15.2 6.1 9.0
Diluted EPS (Net Income) 0.69 0.34 0.50
More Obagi Medical financial information

Obagi Medical Stock Quote & Chart

08/28/08 15:00:12 EST • NASDAQ • 9.96 • Increased by 0.0000 • Increased by 0.0000 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Obagi Medical Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 2.11 3.66 1.55
Price/Earnings Ratio 14.17 15.34 15.75
Price/Book Ratio 4.16 2.93 1.49
Price/Cash Flow Ratio 10.78 12.16 9.68
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Obagi Medical Financial Ratios

Obagi Medical Competitive Intelligence

Allergan L'Oréal PhotoMedex
Annual Sales ($ mil.) 3,938.9 20,831.9 38.7
Employees 7,886 60,851 --
Market Cap ($ mil.) 17,516.2 -- 36.6

Competitive Landscape